Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
Neoplasm Metastasis
×
ruxolitinib
×
Clear all
Filters
3
NCT06397313
2025-09-23
POTAMI-61
Ryvu Therapeutics SA
Phase 2
Recruiting
230 enrolled
NCT02142036
2019-03-13
MetAction
Oslo University Hospital
Phase 2
Completed
50 enrolled